Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO)

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

546

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

April 30, 2027

Conditions
Total Hip Arthroplasty
Interventions
DRUG

Nefopam

20 mg nefopam in 50 ml of saline, during a 30 min infusion, before end of procedure, then a similer bolus every 4 h for 24 h (6 injections in total) + continuous intravenous infusion of placebo (2 mL/h saline)

DRUG

Nefopam

20 mg nefopam in 50 ml of saline, during a 30 min infusion, before end of procedure, then a bolus of placebo every 4 h for 24 h (6 injections in total) + continuous infusion of 100 mg nefopam over 24 h (in 48 mL saline, 2 mL/h)

DRUG

NaCl 0.9%

50 ml of saline, during a 30 min infusion, before end of procedure, followed by a bolus of placebo every 4 hours for 24 hours (6 injections in all) + continuous infusion of placebo (2 mL/h of physiological saline)

Trial Locations (7)

28018

Anaesthesia - Intensive care, Chartres

37044

Anesthesia - intensive care, Tours

41016

Anaesthesia - Intensive care, Blois

44000

Anaesthesia - Intensive care, Nantes

45067

Anaesthesia - Intensive care, Orléans

49933

Anaesthesia - Intensive care, Angers

86021

Anaesthesia - Intensive care, Poitiers

All Listed Sponsors
lead

University Hospital, Tours

OTHER